Important legal notices
   
Contact   |   Search   

European Research Area

Sixth Framework Programme (2002-2006)  

 

EDCTP

The EDCTP initiative

The European Commission's role

Press room

Conferences in 2002:
Barcelona & Brussels (Heysel)

* TUBERCULOSIS

  • Tuberculosis (TB) is a contagious, airborne infection.

  • Infected people incur a 10% risk of developing active TB. If untreated, 50% of patients with active TB will die in a 5- year period. Weakening of the immune system, e.g. via HIV infection, increases the risk of developing active disease.

  • One third of the world's population is currently infected with TB bacilli. If control is not further strengthened it is estimated that, between 2002 and 2020, 1000 million people will be newly infected, over 150 million will get sick and 36 million will die of the disease

  • The global incidence rate of TB is growing annually at approximately 0.4%, but much faster in sub-Saharan Africa and the countries of the former Soviet Union.

  • HIV fuels the TB epidemic. Globally, 9% of all new TB cases in adults are attributable to HIV- infection, but in Africa the figure reaches 31%.

Early detection and treatment of infectious cases is the primary control measure.

Further Information

World Health Organisation page on Tuberculosis: http://www.who.int/tdr/diseases/tb/default.htm

Contact points at the European Commission for EC research on tuberculosis

Ole.Olesen@ec.europa.eu 
Mercedes.Diez-Ruiz-Navarro@ec.europa.eu

Background information

Economic impact

AIDS

Malaria

Tuberculosis

Ethics

 

On-going research funded by the EC

The Sixth Framework
programme (2002-2006)

Life sciences, genomics and biotechnology forhealth

International co-operation activities

The Fifth Framework
programme (1998-2002)

Book of abstracts

International Co-operation

Quality of Life programme

 

 
EDCTP home page I Whom to contact I TOP Top